Companies · Other Health Care

Acuity EyeCare Rollover, LLC

DALLAS · Other Health Care

Diligence memoA one-page analyst read on Acuity EyeCare Rollover, LLC — recommendation, valuation, rhythm, risks.
$5.7M
Total raised · real
1
Rounds
Latest step-up
Top 34%
Sector rank · raised
Series A
Latest stage · inferred · Mon Mar 27 2017 00:00:00 GMT+0000 (Coordinated Universal Time)

Acuity EyeCare Rollover, LLC looks fair against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Fair
  • Modeled value is 0.95× the median modeled value of Series A Other Health Care companies in 2016–2018 (157 peers) — value vs value, same stage and era.
  • Within the normal band (95% of peer median) for its niche.
Dormant
  • Last raise 9.3 yr ago; this sector typically re-raises about every 14 months.
  • Only one round on record and long silent — often defunct, acquired, or gone quiet.

Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.

Issuer-vehicle patternmedium confidence

Acuity EyeCare Rollover, LLC behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.

Issuer structure
Company-like
No recurring-offering pattern strong enough to override normal financing interpretation.
Lifecycle
9.3 yr record
Peak capital year was 2017 with $5.7M across 1 filings.
Market position
ahead of 67% of Other Health Care peers
Capital scale is ahead of 67% of Other Health Care peers; modeled value is above 81% of peers by modeled value. Large capital with mid-pack modeled value can signal an issuer/program profile rather than operating-company growth.
Valuation reliability
Normal applicability
Stage/dilution valuation models are weakest when the issuer is broad-sector, recurring, or vehicle-like.
Operating evidence
Sparse
No clear CEO/founder/principal role is surfaced, so operating-company confidence is lower.
Data quality
Consistent
Canonical totals and visible filing detail are broadly aligned.
What triggered this
  • Legal name looks like an issuer vehicle rather than a product company.
  • No clearly named CEO/founder/principal role in the public records surfaced here.
  • No verified homepage on the profile yet.
  • Capital program peaked in 2017: $5.7M across 1 filings.
  • Largest single filing was $5.7M on 2017-03-27.
How to read the page
  • Read this less like a startup funding journey and more like a capital-raising program.
  • Stage-based valuation and peer labels have lower applicability for this pattern.
  • The more important signal is lifecycle: repeated filings ended years ago, so current activity needs outside confirmation.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

Acuity EyeCare Rollover, LLC is one of 5377 Other Health Care companies tracked from DALLAS. By capital raised it ranks mid-pack (ahead of 67% of sector peers), and in the upper tier by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
12
Investors (latest)
2017
Year incorporated
2017-03-27
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$50M$100M$150M$200MSeries A · 2017-03-27 Raised $5.7M (real) Modeled valuation $115M (est)$5.7M$115MSeries A2017

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Series A$5.7M · 2017

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 33%.

Modeled valuation trajectory
$115.0M
Base estimate est.
$7.3M
Conservative case
$625.3M
Upside case
$25.9M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Aa $4.0M–$15M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Not enough modeled valuation points to chart a trajectory.

Model inputs · modeled:benchmark-stage-stepup-v1
22%
Dilution assumption
Implied ownership sold in the financing.
52%
Survival probability
28% low · 71% high
1.43×/yr
Annual markup
1.80×/yr upside case
6.0 yr
Elapsed time used
9.3 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
Avg between rounds
Capital velocity
9.3 yr
On record since
2017
First round
1
Rounds on file
How it compares to the market

Benchmarked against 5377 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 2.3× above median
This company$5.7M
Sector median$2.4M
Latest round — vs other Series A rounds in sector (real $, this stage) 1.0× above median
This company$5.7M
Sector median$5.6M
Modeled value — vs sector median (estimate, all stages) 5.2× above median
This company$115.0M
Sector median$22.1M

Raised more than 67% of sector peers (real $). Modeled value above 81% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series A) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #81 of 157.

This companyCohort peer
$100.0M$1.0B$1.0M$10.0M$100.0MCapital raised (log)HemoSonics, LLC · Series A Raised $24.9M · modeled $302.7M (est)Airxpanders Inc · Series A Raised $60.0M · modeled $300.5M (est)Mercator Medsystems Inc · Series A Raised $20.5M · modeled $289.2M (est)Simple Contacts Inc. · Series A Raised $24.1M · modeled $285.5M (est)AVG Holdings, Inc. · Series A Raised $14.0M · modeled $282.5M (est)Avia Holdings, Llc · Series A Raised $27.9M · modeled $272.7M (est)Traditions at Rivertown Park, LLC · Series A Raised $13.5M · modeled $272.4M (est)Access Integrated Healthcare, LLC · Series A Raised $13.2M · modeled $265.8M (est)Gauss Surgical, Inc. · Series A Raised $20.5M · modeled $254.2M (est)4WEB, Inc. · Series A Raised $12.5M · modeled $252.2M (est)Iantech, Inc. · Series A Raised $12.2M · modeled $246.7M (est)AbsoluteCARE, Inc. · Series A Raised $25.7M · modeled $242.6M (est)Acuity EyeCare Rollover, LLC (this company) Raised $5.7M · modeled $115.0M (est)Acuity EyeCare Rollover, LLC
CompanyStageRaised · realValue · estvs peer med.
HemoSonics, LLCSeries A$24.9M$302.7M2.50×
Airxpanders IncSeries A$60.0M$300.5M2.48×
Mercator Medsystems IncSeries A$20.5M$289.2M2.39×
Simple Contacts Inc.Series A$24.1M$285.5M2.36×
AVG Holdings, Inc.Series A$14.0M$282.5M2.33×
Avia Holdings, LlcSeries A$27.9M$272.7M2.25×
Traditions at Rivertown Park, LLCSeries A$13.5M$272.4M2.25×
Access Integrated Healthcare, LLCSeries A$13.2M$265.8M2.20×
Gauss Surgical, Inc.Series A$20.5M$254.2M2.10×
4WEB, Inc.Series A$12.5M$252.2M2.08×
Iantech, Inc.Series A$12.2M$246.7M2.04×
AbsoluteCARE, Inc.Series A$25.7M$242.6M2.00×
Acuity EyeCare Rollover, LLC this companySeries A$5.7M$115.0M0.95×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Series A$5.7M2017-03-27$25.9M$115.0M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Series A$5.7M2017-03-27
    • First recorded raise — entered as Series A.
    • 12 investors on this round.
Intelligence
Modeled next raise
$9.1M
Modeled next size est.range $5.9M$14.6M
Last step-up
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Jeff S. Fronterhouse7 other2017-03
F. Barron S. Fletcher III2 other2017-03
Charles W. Matthews1 other2017-03
Douglas C. Shepard1 other2017-03
George C. Gebhardt1 other2017-03
Glenn W. Askew III1 other2017-03
Jeff W. Browning1 other2017-03
Jim C. Denny1 other2017-03
Warren C. Meyer1 other2017-03
Registry & provenance

Acuity EyeCare Rollover, LLC is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1702759
SEC CIK
2017
Incorporated
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Ecph, LlcOther Health CareSeries D+$285.4M$915.4Mnetwork9 shared operators · same sector
Riata Acuity, LPOther Health CareSeries A$7.1M$142.3Mnetwork2 shared operators · same sector · same stage
Acuity EyeCare Rollover II, LLCOther Health CareSeries A$9.8M$61.2Mnetwork1 shared operator · same sector · same stage
Confluence Life Sciences, Inc.Other Health CareSeries A$5.7M$97.5Msame sector · same stage
Aptiv Solutions, Inc.Other Health CareSeries A$5.7M$114.2Msame sector · same stage
Fresenius Medical Care Boone County, LLCOther Health CareSeries A$5.7M$116.0Msame sector · same stage
Nmt Medical IncOther Health CareSeries A$5.8M$116.2Msame sector · same stage
Neodyne Biosciences IncOther Health CareSeries A$5.8M$116.3Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Acuity EyeCare Rollover II, LLCOther Health CareSeries A$61.2M98%
Eyecheq Inc.Other Health CareSeed$18.7M82%
Balance Ophthalmics, Inc.Other Health CareSeed$14.9M81%
Eyevensys S.A.S.Other Health CareSeries A$136.8M81%
PercuVision LLCOther Health CareSeries A$113.4M81%
Surface Ophthalmics, Inc.Other Health CareSeries B$422.4M80%
Rockville Eye Surgery Center, LLCOther Health CareSeed$2.5M80%
Eye C Better Corp.Other Health CarePre-Seed$14.5M80%
Frequently asked
How much funding has Acuity EyeCare Rollover, LLC raised?
Acuity EyeCare Rollover, LLC has raised approximately $5.7M in disclosed capital across 1 recorded financing round, aggregated from public filings.
What is Acuity EyeCare Rollover, LLC's estimated valuation?
Provath's modeled valuation for Acuity EyeCare Rollover, LLC is approximately $115.0M (modeled range $7.3M–$625.3M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Acuity EyeCare Rollover, LLC at?
Acuity EyeCare Rollover, LLC's latest modeled financing stage is Series A. Its most recent recorded round closed around Mon Mar 27.
What does Acuity EyeCare Rollover, LLC do and where is it based?
Acuity EyeCare Rollover, LLC operates in the Other Health Care sector, based in DALLAS.
Explore related

See where Acuity EyeCare Rollover, LLC sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Acuity EyeCare Rollover, LLC, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.